Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
25 sept. 2023 10h00 HE
|
Pharming Group N.V.
Leiden, The Netherlands, September 25, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders...
Pharming Reports On Preliminary Financial Results 2013
06 mars 2014 01h13 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, March 6, 2014 (GLOBE NEWSWIRE) --
Revenues and other income decreased to €7.0 million (2012: €10.9 million) mainly as a result from lower license fees as 2012...
PHARMING AND SALIX ANNOUNCE EXTENSION OF PDUFA ACTION DATE FOR RUCONEST(r)
24 févr. 2014 01h12 HE
|
Pharming Group N.V.
LEIDEN, Netherlands and RALEIGH, N.C., Feb. 24, 2014 (GLOBE NEWSWIRE) -- Pharming Group NV (NYSE Euronext:PHARM) and Salix Pharmaceuticals, Ltd. (Nasdaq:SLXP) today announced that the Food and Drug...
PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST (RECOMBINANT HUMAN C1 ESTERASE INHIBITOR)
08 nov. 2013 01h06 HE
|
Pharming Group N.V.
LEIDEN, Netherlands and SAN DIEGO, Nov. 8, 2013 (GLOBE NEWSWIRE) --
Pharming Group NV (NYSE
Euronext: PHARM) and Santarus, Inc. (NASDAQ: SNTS) announced that new data from
an open-label extension of...
Pharming Reports On Financial Results For The First Nine Months Of 2013
07 nov. 2013 01h10 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 7, 2013 (GLOBE NEWSWIRE) --
Biotech company Pharming Group NV
("Pharming" or "the Company") (NYSE Euronext: PHARM) today published its
financial report for the first nine...
Pharming announces EU12.0 million private equity placement with institutional investors
09 oct. 2013 01h07 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Oct. 9, 2013 (GLOBE NEWSWIRE) --
Biotech company Pharming Group NV
("Pharming" or "the Company") (NYSE Euronext: PHARM) today announced that it has
entered into a private...
Pharming's Marketing Authorization Application for Rhucin -- RHC1INH -- Accepted for Review by EMEA
17 août 2006 12h58 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Aug. 17, 2006 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming") (Euronext:PHARM) (PHARM.AS) announced today that its Marketing Authorization Application (MAA) for...
Pharming Presents rhC1INH Update at International Meetings
17 nov. 2005 02h13 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 17, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that the Company presented clinical...
Pharming Candidate for Amsterdam Midkap Index on Euronext
09 nov. 2005 02h18 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 09, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that it has been selected by Euronext...
Pharming Announces Results for First Nine Months 2005
03 nov. 2005 01h24 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 3, 2005 (PRIMEZONE) -- Highlights: upcoming product filings, licensing progress and pipeline expansion. Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM)...